tert-Butyl (2R,4S)-4-fluoropyrrolidine-2-carboxylate, 95%, 5g

2,4-Dichloro-N-(S)-pyrrolidin-3-yl-benzenesulfonamide hydrochloride, 95.0%, 250mg

tert-Butyl (2-amino-5-methoxyphenyl)carbamate, 95.0%, 10g

3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4'-fluorobenzophenone, 97.0%, 1g

2-(1H-Pyrazol-3-yl)aniline, 95.0%, 250mg

2-(3-Chlorophenyl)thiazole-4-carboxylic acid, 95.0%, 5g

1-(Chloromethyl)-4-vinylbenzene, 500 ppm t-Butylcatechol inhibitor, 90.0%, 25g

4-Chloro-5-methoxy-pyrimidin-2-ylamine, 95.0%, 1g

3-((2-Hydroxyethyl)amino)benzoic acid, 97%, 500mg

2-Butanol, min. 98.5%, for synthesis, 25 l, plastic packaging.

(4-(Pyrimidin-2-yl)phenyl)methanamine hydrochloride, 95.0%, 250mg

4-iodo-1-(2,2,2-trifluoroethyl)-1H-pyrazole, 95.0%, 250mg

[(3-methyl-4-pyridinyl)methyl]amine dihydrochloride, 95.0%, 250mg